Current NHS consultant posts held
Consultant hepatologist, Leeds Teaching Hospitals NHS Trust
Research interests
Steatotic liver disease, fatty liver disease, alcohol related liver disease
Personal interests
Running, multisport
Awards received
National clinical impact award 2025
Publications
Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD
S Colosimo, H Miller, DA Koutoukidis, T Marjot, GD Tan, DJ Harman, ...
Diabetes research and clinical practice 217, 111820
Healthcare interactions prior to first hospital admission with alcohol‐related liver disease
H Lewis, R Parker, Z Ul‐Haq, A Lucas, C Cohen, N Vergis, M Thursz
Liver International
Essential blood testing in the patient using androgenic anabolic steroids: a clinical practice guideline for primary care
SM Gibbons, M Moulding, K Bailey, K Stuart, S Wiffen, AJP Lewington, ...
British Journal of General Practice 74 (741), 187-190
Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation study
H Miller, D Harman, GP Aithal, P Manousou, JF Cobbold, R Parker, ...
BMJ open 14 (1), e074918
Quality standards for the management of alcohol-related liver disease: consensus recommendations from the British Association for the Study of the Liver and British Society of …
R Parker, M Allison, S Anderson, R Aspinall, S Bardell, V Bains, ...
BMJ Open Gastroenterology 10 (1), e001221
Alcohol-Related Liver Disease: Is There a Safe Alcohol Consumption Limit for Liver Disease?
K Pekarska, R Parker
Seminars in Liver Disease
Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis
S Amonker, A Houshmand, A Hinkson, I Rowe, R Parker
Hepatology Communications 7 (5), e0133
Extra‐hepatic morbidity and mortality in alcohol‐related liver disease: Systematic review and meta‐analysis
MD Theodoreson, GP Aithal, M Allison, M Brahmania, E Forrest, ...
Liver International 43 (4), 763-772
Meta‐analysis: Enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases
A Hinkson, H Lally, H Gibson, R Jones, IA Rowe, B Shinkins, R Parker
Alimentary Pharmacology & Therapeutics 57 (7), 750-762
The natural history of advanced chronic liver disease defined by transient elastography
JE Shearer, R Jones, R Parker, J Ferguson, IA Rowe
Clinical Gastroenterology and Hepatology 21 (3), 694-703. e8
Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic review
KWM Abeysekera, I Macpherson, K Glyn-Owen, S McPherson, R Parker, ...
The Lancet Gastroenterology & Hepatology 7 (8), 770-780